Speakers

Megan Bomgaars

Global Quincy Jones Exceptional Advocacy Award Winner, Emmy Award Winning Actress & Public Speaker

Mike Rafii, MD, PhD

Associate Professor of Clinical Neurology, Keck School of Medicine, University of Southern California; Medical Director of the Alzheimer’s Therapeutic Research Institute and the NIH-funded Alzheimer’s Clinical Trial Consortium; Principal Investigator for the Down Syndrome Biomarker Initiative; Steering Committee Member of the NIH-funded Alzheimer’s Biomarker Consortium

Alzheimer’s Disease and Down Syndrome: Research Today and What the Future May Hold

Laurie Ryan, PhD

Chief of the Dementias of Aging Branch, Division of Neuroscience at the National Institute of Aging, part of the National Institutes of Health

NIH Priorities for Alzheimer’s Disease and Down Syndrome

Huntington Potter, PhD

Professor of Neurology, University of Colorado School of Medicine; Rocky Mountain Alzheimer’s Disease Center Director, Alzheimer’s Disease Program Director at the Linda Crnic Institute for Down Syndrome

Alzheimer’s Disease Overall State of Research

Joaquín Espinosa, PhD

Executive Director, Linda Crnic Institute for Down Syndrome, Professor in the Department of Pharmacology at the University of Colorado School of Medicine, Co-Leader of the Molecular Oncology program at the University of Colorado Cancer Center, and founding Director of the Functional Genomics Facility at the University of Colorado

Immune Dysregulation, Alzheimer’s Disease and Down Syndrome

Peter Bulova, MD

Associate Professor of Medicine, Director of the University of Pittsburgh Adult Down Syndrome Center, Co-Director of the Magee Center for Women with Disabilities, Board President of the Down Syndrome Medical Interest Group (DSMIG-USA)

Findings from the Pittsburgh Adult Down Syndrome Clinic

Dennis McGuire, LCSW, PhD

Senior Consultant on Adult Medical Strategies for Global Down Syndrome Foundation, Down Syndrome

Avoiding Misdiagnosis of Alzheimer’s in People with Down Syndrome